Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “VKA”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Not applicableStudy completedNCT03532724
What this trial is testing

Clinical Outcomes From Patient Self-management of Antivitamin K Treatment

Who this might be right for
Self Management of Oral Anticoagulation With VKA Therapy
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 927
Testing effectiveness (Phase 2)Study completedNCT05205863
What this trial is testing

Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation

Who this might be right for
Healthy Volunteers
Prothya Biosolutions 69
Not applicableStudy completedNCT03462446
What this trial is testing

Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events

Who this might be right for
Atrial Fibrillation
Bayer 249
Not applicableStudy completedNCT01029743
What this trial is testing

Xarelto Regulatory Post-Marketing Surveillance

Who this might be right for
Venous Thromboembolism
Bayer 3,388
Not applicableStudy completedNCT03093233
What this trial is testing

Multicenter Analysis of Oral Anticoagulant-associated ICH - Part Two

Who this might be right for
Anticoagulation Associated (VKA & NOAC) Intracerebral Hemorrhage
University of Erlangen-Nürnberg Medical School 1,369
Not applicableStudy completedNCT04518735
What this trial is testing

Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study)

Who this might be right for
Covid19
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,707
Testing effectiveness (Phase 2)Study completedNCT01533441
What this trial is testing

Vitamin K2 Intervention in Patients With Vitamin K Antagonists

Who this might be right for
Thrombosis
Danisco 50
Not applicableStudy completedNCT02240667
What this trial is testing

Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,506
Post-approval studies (Phase 4)Study completedNCT00860106
What this trial is testing

Echo Doppler (ED )Score and D-dimer (DD) Level in the Evaluation of VTE Recurrence After Anticoagulant Treatment Cessation

Who this might be right for
Previous Vka TreatmentPrevious Proximal VTE
University Hospital, Grenoble 222
Not applicableUnknownNCT02706080
What this trial is testing

Registry of Patient With Antithrombotic Agents Admitted to an Emergency Department

Who this might be right for
Antithrombotic Agents
University Hospital, Clermont-Ferrand 10
Not applicableStudy completedNCT02960334
What this trial is testing

Screening for Actionable Atrial Fibrillation During Preoperative Consultation With the MyDiagnostick

Who this might be right for
Atrial Fibrillation
Martini Hospital Groningen 505
Not applicableStudy completedNCT01362933
What this trial is testing

National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients

Who this might be right for
NeoplasmsVenous Thromboembolism
Floralis 502
Not applicableStudy completedNCT02319460
What this trial is testing

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

Who this might be right for
Hemorrhage
CSL Behring 2,238
Large-scale testing (Phase 3)UnknownNCT06143787
What this trial is testing

Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth Extraction

Who this might be right for
Bleeding From TeethBleeding Prophylaxis
Hyloris Developments 280
Testing effectiveness (Phase 2)WithdrawnNCT04002011
What this trial is testing

DOAC Versus VKA After Cardiac Surgery

Who this might be right for
Anticoagulant-induced Bleeding
Laval University
Large-scale testing (Phase 3)Ended earlyNCT02618577
What this trial is testing

Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes

Who this might be right for
Atrial High Rate Episodes
Atrial Fibrillation Network 2,608
Not applicableStudy completedNCT02687867
What this trial is testing

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 56,039
Not applicableUnknownNCT04462614
What this trial is testing

Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA

Who this might be right for
Chronic HemolysisVKAAnticoagulants / Administration & Dosage+7 more
CHU de Reims 49
Post-approval studies (Phase 4)Study completedNCT01727453
What this trial is testing

Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.

Who this might be right for
Acute Gastrointestinal Bleeding
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 40
Not applicableNot Yet RecruitingNCT07570511
What this trial is testing

Point of Care Testing INR in Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid SyndromeVitamine K Antagonist (VKA) Treatment
Central Hospital, Nancy, France 150
Load More Results